Carbiotix AB (publ) (NGM:CRBX)

Sweden flag Sweden · Delayed Price · Currency is SEK
9.94
-0.02 (-0.20%)
At close: Jun 30, 2025
125.91%
Market Cap 46.05M
Revenue (ttm) 2.27M
Net Income (ttm) -16.07M
Shares Out 4.64M
EPS (ttm) -3.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 98
Average Volume 2,511
Open 8.52
Previous Close 9.96
Day's Range 8.52 - 9.98
52-Week Range 3.92 - 19.00
Beta 0.74
RSI 45.04
Earnings Date Aug 6, 2025

About Carbiotix AB

Carbiotix AB (publ), a biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops CarbiAXOS, a second-generation prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides that is customized to meet customer needs to the production of short chain fatty acids or any other effect; and LinkGut, a health test. Carbiotix AB (publ) was... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 8
Stock Exchange Nordic Growth Market
Ticker Symbol CRBX
Full Company Profile

Financial Performance

In 2024, Carbiotix AB's revenue was 2.86 million, a decrease of -33.38% compared to the previous year's 4.29 million. Losses were -16.13 million, 19.7% more than in 2023.

Financial Statements

News

There is no news available yet.